$COPR
Idaho Copper Corp

2024 Q4 Form 10-Q Financial Statement

#000149315224049763 Filed on December 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.205M
YoY Change 404.89%
Operating Profit -$2.205M
YoY Change 404.89%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$147.6K
YoY Change 2.7%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.353M
YoY Change 305.3%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 253.5M shares
Diluted Shares Outstanding 253.5M shares

Balance Sheet

Concept 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $18.73K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $134.7K
Receivables
Other Receivables
Total Short-Term Assets $153.4K
YoY Change 263.74%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $120.8K
YoY Change 20.84%
TOTAL ASSETS
Total Short-Term Assets $153.4K
Total Long-Term Assets $120.8K
Total Assets $274.3K
YoY Change 92.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.651M
YoY Change 102.86%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.180M
YoY Change -19.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.651M
Total Long-Term Liabilities $4.180M
Total Liabilities $5.831M
YoY Change -2.69%
SHAREHOLDERS EQUITY
Retained Earnings -$36.44M
YoY Change 22.97%
Common Stock $256.9K
YoY Change 20.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.556M
YoY Change
Total Liabilities & Shareholders Equity $274.3K
YoY Change 92.91%

Cashflow Statement

Concept 2024 Q4
OPERATING ACTIVITIES
Net Income -$2.353M
YoY Change 305.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
IDAHO COPPER CORPORATION
CY2024Q4 us-gaap Assets Current
AssetsCurrent
153447 usd
CY2024Q4 us-gaap Assets
Assets
274290 usd
CY2024Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
385958 usd
CY2024Q4 us-gaap Interest Payable Current
InterestPayableCurrent
284279 usd
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
186.67 shares
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
186.67 shares
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83702
dei City Area Code
CityAreaCode
(208)
dei Local Phone Number
LocalPhoneNumber
274-9220
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
COPR
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q4 us-gaap Cash
Cash
18731 usd
CY2024Q1 us-gaap Cash
Cash
30146 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
134716 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21624 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
51770 usd
CY2024Q1 us-gaap Assets
Assets
151770 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
434519 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1115723 usd
CY2024Q4 us-gaap Professional Fees
ProfessionalFees
285336 usd
CY2024Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
CY2024Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
28800 usd
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1704024 usd
CY2024Q4 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
126808 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
2204968 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2204968 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Entity Central Index Key
EntityCentralIndexKey
0001263364
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2024Q1 us-gaap Longterm Transition Bond Current
LongtermTransitionBondCurrent
usd
CY2024Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2024Q4 us-gaap Revenues
Revenues
usd
CY2023Q4 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2024Q4 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
usd
COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
usd
CY2024Q4 COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2024Q2 COPR Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2024Q2 COPR Stock Issued During Period Value Stock Options One Exercised
StockIssuedDuringPeriodValueStockOptionsOneExercised
usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2024Q3 COPR Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
usd
COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
COPR Noncash Cashless Exercise Of Warrants And Options
NoncashCashlessExerciseOfWarrantsAndOptions
usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q4 COPR Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
usd
CY2024Q1 COPR Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
usd
CY2024Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity File Number
EntityFileNumber
333-108715
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0221494
dei Entity Address Address Line1
EntityAddressAddressLine1
800 W. Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1460
dei Entity Address City Or Town
EntityAddressCityOrTown
Boise
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
256942937 shares
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20843 usd
CY2024Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
100000 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
100000 usd
CY2024Q4 us-gaap Notes Payable Current
NotesPayableCurrent
25000 usd
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20843 usd
CY2024Q4 us-gaap Longterm Transition Bond Current
LongtermTransitionBondCurrent
546000 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1651051 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1920377 usd
CY2024Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
2589000 usd
CY2024Q1 us-gaap Long Term Transition Bond
LongTermTransitionBond
3135000 usd
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
623999 usd
CY2024Q4 COPR Interest Payable Non Current
InterestPayableNonCurrent
1590724 usd
CY2024Q1 COPR Interest Payable Non Current
InterestPayableNonCurrent
533003 usd
CY2024Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4179724 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4292002 usd
CY2024Q4 us-gaap Liabilities
Liabilities
5830775 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6212379 usd
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
23 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
23 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
256942937 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
256942937 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214647732 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214647732 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
256943 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
214648 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30625010 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25336048 usd
CY2024Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
11000 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36438438 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31600305 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-5556485 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6060609 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
274290 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151770 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
100821 usd
us-gaap Professional Fees
ProfessionalFees
625945 usd
us-gaap Professional Fees
ProfessionalFees
357622 usd
CY2023Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
282500 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
512650 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
639500 usd
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
10500 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
171885 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
31500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2258080 usd
us-gaap Share Based Compensation
ShareBasedCompensation
140739 usd
CY2023Q4 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
42905 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
554830 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
67459 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
436726 usd
us-gaap Operating Expenses
OperatingExpenses
4123390 usd
us-gaap Operating Expenses
OperatingExpenses
1236820 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-436726 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4123390 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1236820 usd
CY2023Q4 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
68566 usd
COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
203812 usd
CY2023Q4 COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
11316 usd
COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
19490 usd
COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
22633 usd
CY2024Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
440 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6846 usd
CY2024Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
148053 usd
CY2023Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
63851 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
296795 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
279725 usd
CY2024Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-147613 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-143733 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-309439 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-506170 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-2352581 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-580459 usd
us-gaap Net Income Loss
NetIncomeLoss
-4432829 usd
us-gaap Net Income Loss
NetIncomeLoss
-1742990 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253460307 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253460307 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
210365353 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210365353 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242282623 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
242282623 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
210175251 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210175251 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4620577 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140739 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-575001 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5054839 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
103846 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-587531 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5538524 usd
CY2023Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
269085 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-580459 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5849898 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6060609 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6060609 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1753300 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1048793 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
189248 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1044266 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4518839 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
320084 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
364808 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-50000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1035981 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4919928 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4919928 usd
CY2024Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12000 usd
CY2024Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1704024 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-2352581 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-2352581 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-5556485 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-5556485 usd
us-gaap Net Income Loss
NetIncomeLoss
-4432829 usd
us-gaap Net Income Loss
NetIncomeLoss
-1742990 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2258080 usd
us-gaap Share Based Compensation
ShareBasedCompensation
140739 usd
COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
203812 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19490 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
22633 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
113092 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
24472 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52400 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
123032 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
22676 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
481387 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-226276 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-180999 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2071799 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-614860 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
201200 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
2035384 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2060384 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
201200 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11415 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-413660 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30146 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
431374 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18731 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17714 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1048793 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
269085 usd
COPR Noncash Cashless Exercise Of Warrants And Options
NoncashCashlessExerciseOfWarrantsAndOptions
20563 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_804_eus-gaap--NatureOfOperations_z5GxFBqodZNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_824_zOIw3hqp6rzj">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased <span id="xdx_909_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20220203__20220203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zyJ9LLTPdXn7" title="Buyer purchased common stock shares">16,644,820</span> shares of common stock of the Company from the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zf9f5MfEUzii" title="Number of shares issued">182,240,000</span> shares of the Company’s common stock, par value $<span id="xdx_904_eus-gaap--EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zN7EBTX7WjVa" title="Common stock, par value">0.001</span> per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ICUMO Background</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of exploring its mineral rights interests in the United States and as of the date of these condensed consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q4 us-gaap Cash
Cash
18731 usd
us-gaap Net Income Loss
NetIncomeLoss
-4432829 usd
CY2024Q4 COPR Working Capital Deficit
WorkingCapitalDeficit
1497605 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zj2QtJPJjcfh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zzyXyD3aBnb5">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0 usd
CY2024Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
405305 usd
CY2024Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
3135000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
0.125
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3385000 shares
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
186.67 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
23 shares
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
256942937 shares
CY2024Q4 COPR Common Stock Shares Issuable
CommonStockSharesIssuable
256942937 shares
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
256942937 shares
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
22646000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
6566000 shares
CY2023Q1 us-gaap Share Price
SharePrice
0.125
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2027-12-31
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
189248 usd
CY2024Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
568000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period.
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1704024 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2258080 usd
us-gaap Share Based Compensation
ShareBasedCompensation
140739 usd
CY2024Q1 us-gaap Payments To Acquire Leases Held For Investment
PaymentsToAcquireLeasesHeldForInvestment
100000 usd
CY2024Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y29D
CY2024Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2024Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P13M
us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P3Y
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
43200 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
43200 usd
CY2024Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22357 usd
CY2024Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
20843 usd
us-gaap Payments For Rent
PaymentsForRent
143085 usd
us-gaap Payments For Rent
PaymentsForRent
21000 usd
CY2024Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1312283 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
751916 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-452604 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-285980 usd
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-107763 usd
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-68090 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
560367 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
354070 usd
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1312283 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
751916 usd
CY2024Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1312283 usd
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
751916 usd
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1312283 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
751916 usd
us-gaap Valuation Allowance Deferred Tax Asset Explanation Of Change
ValuationAllowanceDeferredTaxAssetExplanationOfChange
Company, the net deferred tax assets for 2023 were fully offset by a 100% valuation allowance.
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1312283 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
751916 usd
CY2022Q4 us-gaap Partners Capital Account Units Sold In Private Placement
PartnersCapitalAccountUnitsSoldInPrivatePlacement
4333333 shares
CY2024Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
880000 shares
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
201200 usd
CY2024Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.23

Files In Submission

Name View Source Status
0001493152-24-049763-index-headers.html Edgar Link pending
0001493152-24-049763-index.html Edgar Link pending
0001493152-24-049763.txt Edgar Link pending
0001493152-24-049763-xbrl.zip Edgar Link pending
copr-20241031.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
copr-20241031_cal.xml Edgar Link unprocessable
copr-20241031_def.xml Edgar Link unprocessable
copr-20241031_lab.xml Edgar Link unprocessable
copr-20241031_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending